Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Gene expression of RNAP II, JBP1 and JBP2 in Leishmania major exposed to antimonials, amphotericin B and paromomycin

Ajamein V, Eslami G, Ahmadian S, Khamesipour A, Elloumi M.

Ann Parasitol. 2018;64(3):181-187. doi: 10.17420/ap6403.149.

PMID:
30316208
2.

The Potential Role of Humans in the Transmission Cycle of Leishmania major (Kinetoplastida: Trypanosomatidae), the Causative Agent of the Old World Zoonotic Cutaneous Leishmaniasis.

Fatemi M, Yaghoobi-Ershadi MR, Mohebali M, Saeidi Z, Veysi A, Gholampour F, Akhondi B, Karimi A, Arandian MH, Amin Mohammadi AM, Rassi Y, Zahraei-Ramazani A, Khamesipour A, Akhavan AA.

J Med Entomol. 2018 Jul 5. doi: 10.1093/jme/tjy110. [Epub ahead of print]

PMID:
30124876
3.

Novel Nanosized Chitosan-Betulinic Acid Against Resistant Leishmania Major and First Clinical Observation of such parasite in Kidney.

Zadeh Mehrizi T, Shafiee Ardestani M, Haji Molla Hoseini M, Khamesipour A, Mosaffa N, Ramezani A.

Sci Rep. 2018 Aug 6;8(1):11759. doi: 10.1038/s41598-018-30103-7.

4.

Reduction toxicity of Amphotericin B through loading into a novel nanoformulation of anionic linear globular dendrimer for improve treatment of leishmania major.

Mehrizi TZ, Ardestani MS, Khamesipour A, Hoseini MHM, Mosaffa N, Anissian A, Ramezani A.

J Mater Sci Mater Med. 2018 Jul 28;29(8):125. doi: 10.1007/s10856-018-6122-9.

PMID:
30056571
5.

Development of a new live attenuated Leishmania major p27 gene knockout: Safety and immunogenicity evaluation in BALB/c mice.

Elikaee S, Mohebali M, Rezaei S, Eslami H, Khamesipour A, Keshavarz H, Eshraghian MR.

Cell Immunol. 2018 Oct;332:24-31. doi: 10.1016/j.cellimm.2018.07.002. Epub 2018 Jul 17.

PMID:
30053997
6.

AUCTSP: an improved biomarker gene pair class predictor.

Kagaris D, Khamesipour A, Yiannoutsos CT.

BMC Bioinformatics. 2018 Jun 26;19(1):244. doi: 10.1186/s12859-018-2231-1.

7.

The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome.

Emami T, Rezayat SM, Khamesipour A, Madani R, Habibi G, Hojatizade M, Jaafari MR.

Artif Cells Nanomed Biotechnol. 2018 Apr 1:1-10. doi: 10.1080/21691401.2018.1457042. [Epub ahead of print]

PMID:
29607698
8.

Evaluation of Association Between the Serum Levels of MMP-9 and MMP-9/TIMPs With Soluble Forms of Selectins and Itching Induced by Sulfur Mustard.

Askari N, Ghazanfari T, Naghizadeh MM, Moin A, Khamesipour A, Pourfarzam S, Hassan ZM.

Iran J Pathol. 2017 Summer;12(3):257-264. Epub 2017 Jan 27.

9.

Rearing and Biology of Phlebotomus sergenti, the Main Vector of Anthroponotic Cutaneous Leishmaniasis in Iran.

Veysi A, Yaghoobi-Ershadi MR, Rassi Y, Hosseini-Vasoukolaei N, Jeddi-Tehrani M, Rezaee-Node A, Gholampour F, Saeidi Z, Fatemi M, Arandian MH, Khamesipour A, Akhavan AA.

J Arthropod Borne Dis. 2017 Dec 30;11(4):504-514. eCollection 2017 Dec.

10.

Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.

Olliaro P, Grogl M, Boni M, Carvalho EM, Chebli H, Cisse M, Diro E, Fernandes Cota G, Erber AC, Gadisa E, Handjani F, Khamesipour A, Llanos-Cuentas A, López Carvajal L, Grout L, Lmimouni BE, Mokni M, Nahzat MS, Ben Salah A, Ozbel Y, Pascale JM, Rizzo Molina N, Rode J, Romero G, Ruiz-Postigo JA, Gore Saravia N, Soto J, Uzun S, Mashayekhi V, Vélez ID, Vogt F, Zerpa O, Arana B.

PLoS Negl Trop Dis. 2018 Jan 12;12(1):e0006141. doi: 10.1371/journal.pntd.0006141. eCollection 2018 Jan.

11.

Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model.

Jafari I, Heravi Shargh V, Shahryari M, Abbasi A, Jaafari MR, Khamesipour A, Badiee A.

Immunobiology. 2018 Jun - Jul;223(6-7):493-500. doi: 10.1016/j.imbio.2017.12.003. Epub 2017 Dec 28.

PMID:
29317110
12.

The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model.

Firouzmand H, Sahranavard M, Badiee A, Khamesipour A, Alavizadeh SH, Samiei A, Soroush D, Tavassoti Kheiri M, Mahboudi F, Jaafari MR.

Immunopharmacol Immunotoxicol. 2018 Feb;40(1):72-82. doi: 10.1080/08923973.2017.1407941. Epub 2017 Dec 6.

PMID:
29210292
13.

Liposomal adjuvant development for leishmaniasis vaccines.

Askarizadeh A, Jaafari MR, Khamesipour A, Badiee A.

Ther Adv Vaccines. 2017 Aug;5(4-5):85-101. doi: 10.1177/2051013617741578. Epub 2017 Nov 15. Review.

14.

Comparison of clinical efficacy and safety of thermotherapy versus cryotherapy in treatment of skin warts: A randomized controlled trial.

Izadi Firouzabadi L, Khamesipour A, Ghandi N, Hosseini H, Teymourpour A, Firooz A.

Dermatol Ther. 2018 Jan;31(1). doi: 10.1111/dth.12564. Epub 2017 Oct 30.

PMID:
29082602
15.

Assessing the Ovarian Accessory Glands to Determine the Parity of Phlebotomus papatasi, Vector of Zoonotic Cutaneous Leishmaniasis, under Laboratory Condition.

Fatemi M, Yaghoobi-Ershadi MR, Mohebali M, Saeidi Z, Veysi A, Khamesipour A, Akhavan AA.

J Arthropod Borne Dis. 2017 Mar 14;11(1):161-165. eCollection 2017 Mar.

16.

Iranian Native Plants on Treatment of Cutaneous Leishmaniosis: A Narrative Review.

Moghaddas E, Khamesipour A, Mohebali M, Fata A.

Iran J Parasitol. 2017 Jul-Sep;12(3):312-322. Review.

17.

PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model.

Naseri H, Eskandari F, Jaafari MR, Khamesipour A, Abbasi A, Badiee A.

Parasite Immunol. 2017 Nov;39(11). doi: 10.1111/pim.12492. Epub 2017 Oct 6.

PMID:
28921566
18.

Genetic Diversity and Phylogenetic Analysis of the Iranian Leishmania Parasites Based on HSP70 Gene PCR-RFLP and Sequence Analysis.

Nemati S, Fazaeli A, Hajjaran H, Khamesipour A, Anbaran MF, Bozorgomid A, Zarei F.

Korean J Parasitol. 2017 Aug;55(4):367-374. doi: 10.3347/kjp.2017.55.4.367. Epub 2017 Aug 31.

19.

Identification of etiologic agents of cutaneous Leishmaniasis in palpebral position followed by effective therapy.

Saberi S, Arjmand R, Khamesipour A, Nilforoushzadeh MA, Sayareh S, Hejazi SH.

J Educ Health Promot. 2017 Jun 5;6:44. doi: 10.4103/jehp.jehp_118_14. eCollection 2017.

20.

Topical treatment with nanoliposomal Amphotericin B reduces early lesion growth but fails to induce cure in an experimental model of cutaneous leishmaniasis caused by Leishmania mexicana.

Varikuti S, Oghumu S, Saljoughian N, Pioso MS, Sedmak BE, Khamesipour A, Satoskar AR.

Acta Trop. 2017 Sep;173:102-108. doi: 10.1016/j.actatropica.2017.06.004. Epub 2017 Jun 9.

21.

Modulation of the Immune Response to DNA Vaccine Encoding Gene of 8-kDa Subunit of Echinococcus granulosus Antigen B Using Murine Interleukin-12 Plasmid in BALB/c Mice.

Azizi H, Kazemi B, Bandehpour M, Mohebali M, Khamesipour A, Aryaeipour M, Yaghoobi H, Rokni MB.

Iran J Parasitol. 2016 Oct-Dec;11(4):480-489.

22.

Aquaglyceroporin1 gene expression in antimony resistance and susceptible Leishmania major isolates.

Eslami G, Zarchi MV, Moradi A, Hejazi SH, Sohrevardi SM, Vakili M, Khamesipour A.

J Vector Borne Dis. 2016 Oct-Dec;53(4):370-374.

23.

The importance of the patient voice in vaccination and vaccine safety-are we listening?

Holt D, Bouder F, Elemuwa C, Gaedicke G, Khamesipour A, Kisler B, Kochhar S, Kutalek R, Maurer W, Obermeier P, Seeber L, Trusko B, Gould S, Rath B.

Clin Microbiol Infect. 2016 Dec 1;22 Suppl 5:S146-S153. doi: 10.1016/j.cmi.2016.09.027. Epub 2016 Dec 6.

24.

Anti Leishmania activity of Lucilia sericata and Calliphora vicina maggots in laboratory models.

Sanei-Dehkordi A, Khamesipour A, Akbarzadeh K, Akhavan AA, Mir Amin Mohammadi A, Mohammadi Y, Rassi Y, Oshaghi MA, Alebrahim Z, Eskandari SE, Rafinejad J.

Exp Parasitol. 2016 Nov;170:59-65. doi: 10.1016/j.exppara.2016.08.007. Epub 2016 Aug 24.

PMID:
27567983
25.
26.

Molecular Dynamics Simulation and Docking Studies of Selenocyanate Derivatives as Anti-Leishmanial Agents.

Iman M, Kaboutaraki HB, Jafari R, Hosseini SA, Moghimi A, Khamesipour A, Harchegani AB, Davood A.

Comb Chem High Throughput Screen. 2016;19(10):847-854. doi: 10.2174/1386207319666160907102235.

PMID:
27604957
27.

In vivo/In vitro immune responses to L. major isolates from patients with no clinical response to Glucantime.

Saberi S, Arjmand R, Soleimanifard S, Khamesipour A, Hosseini SM, Salehi M, Varshosaz J, Palizban AA, Hejazi SH.

Adv Biomed Res. 2016 Jul 29;5:126. doi: 10.4103/2277-9175.187000. eCollection 2016.

28.

Differential expression profiles of the salivary proteins SP15 and SP44 from Phlebotomus papatasi.

Hosseini-Vasoukolaei N, Idali F, Khamesipour A, Yaghoobi-Ershadi MR, Kamhawi S, Valenzuela JG, Edalatkhah H, Arandian MH, Mirhendi H, Emami S, Jafari R, Saeidi Z, Jeddi-Tehrani M, Akhavan AA.

Parasit Vectors. 2016 Jun 24;9(1):357. doi: 10.1186/s13071-016-1633-z.

29.

The role of ISCOMATRIX bilayer composition to induce a cell mediated immunity and protection against leishmaniasis in BALB/c mice.

Mehravaran A, Jaafari MR, Jalali SA, Khamesipour A, Ranjbar R, Hojatizade M, Badiee A.

Iran J Basic Med Sci. 2016 Feb;19(2):178-86.

30.

Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB/c mice-based experimental setting.

Fakhraee F, Badiee A, Alavizadeh SH, Jalali SA, Chavoshian O, Khamesipour A, Mahboudi F, Jaafari MR.

Acta Trop. 2016 Jul;159:211-8. doi: 10.1016/j.actatropica.2016.04.004. Epub 2016 Apr 6.

PMID:
27060774
31.

Seasonal and Physiological Variations of Phlebotomus papatasi Salivary Gland Antigens in Central Iran.

Hosseini-Vasoukolaei N, Mahmoudi AR, Khamesipour A, Yaghoobi-Ershadi MR, Kamhawi S, Valenzuela JG, Arandian MH, Mirhendi H, Emami S, Saeidi Z, Idali F, Jafari R, Jeddi-Tehrani M, Akhavan AA.

J Arthropod Borne Dis. 2015 Jun 27;10(1):39-49. eCollection 2016 Mar.

32.

Tumour Necrosis Factor-alpha (TNF-α) and its soluble receptor type 1 (sTNFR I) in human active and healed leishmaniases.

Nateghi Rostami M, Seyyedan Jasbi E, Khamesipour A, Mohammadi AM.

Parasite Immunol. 2016 Apr;38(4):255-60. doi: 10.1111/pim.12305.

33.

Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation.

Mehravaran A, Jaafari MR, Jalali SA, Khamesipour A, Tafaghodi M, Hojatizade M, Abbasi A, Badiee A.

Iran J Immunol. 2015 Dec;12(4):274-87. doi: IJIv12i4A5.

34.

Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80.

Mobasheri M, Attar H, Rezayat Sorkhabadi SM, Khamesipour A, Jaafari MR.

Molecules. 2015 Dec 24;21(1):E6. doi: 10.3390/molecules21010006.

35.

Plasma levels of tumor necrosis factor-alpha (TNF-α), TNF-α soluble receptor type 1 (sTNFR I) and IL-22 in human leishmaniasis.

Nateghi Rostami M, Seyyedan Jasbi E, Khamesipour A, Miramin Mohammadi A.

Trop Biomed. 2015 Sep;32(3):478-84.

PMID:
26695208
36.

Molecular Cloning and Expression an 8-kDa Subunit of Antigen B from G1 strain of Echinococcus granulosus.

Azizi H, Kazemi B, Bandehpour M, Mohebali M, Khamesipour A, Aryaeipour M, Rokni MB.

Iran J Public Health. 2015 Jul;44(7):962-8.

37.
38.

Antigenic profile of heat-killed versus thimerosal-treated Leishmania major using sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Arjmand R, Fard SS, Saberi S, Tolouei S, Khamesipour A, Hejazi SH.

Adv Biomed Res. 2015 Jun 4;4:128. doi: 10.4103/2277-9175.158068. eCollection 2015.

39.

Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report.

Mortazavi H, Mohebali M, Taslimi Y, Sadeghipour P, Ansari M, Kamyab K, Talebi M, Khamesipour A.

Iran J Parasitol. 2015 Apr-Jun;10(2):296-300.

40.

Frequency of seropositivity against infectious agents amongst pemphigus vulgaris patients: a case-control study on Strongyloides stercoralis, Helicobacter pylori, Toxoplasma gondii, Leishmania major, and Epstein-Barr virus.

Mortazavi H, Hejazi P, Khamesipour A, Mohebali M, Ehsani AH, Mohammadi Y, Farahani IV, Amirzargar AA.

Int J Dermatol. 2015 Nov;54(11):e458-65. doi: 10.1111/ijd.12869. Epub 2015 Jul 14.

PMID:
26175264
41.

Canine visceral leishmaniasis: seroprevalence survey of asymptomatic dogs in an endemic area of northwestern Iran.

Barati M, Mohebali M, Alimohammadian MH, Khamesipour A, Akhoundi B, Zarei Z.

J Parasit Dis. 2015 Jun;39(2):221-4. doi: 10.1007/s12639-013-0325-2. Epub 2013 Jun 20.

42.

Quality Control of Widely Used Therapeutic Recombinant Proteins by a Novel Real-Time PCR Approach.

Mamnoon B, Naserpour Farivar T, Kamyab AR, Ilghari D, Khamesipour A, Karimi Arzenani M.

Iran Biomed J. 2016;20(1):56-62. Epub 2015 Jun 6.

43.

A comprehensive review of cutaneous leishmaniasis in kerman province, southeastern iran-narrative review article.

Sharifi I, Aflatoonian MR, Fekri AR, Hakimi Parizi M, Aghaei Afshar A, Khosravi A, Sharifi F, Aflatoonian B, Khamesipour A, Dowlati Y, Modabber F, Nadim A.

Iran J Public Health. 2015 Mar;44(3):299-307. Review.

44.
45.

Molecular identification of Leishmania tropica infections in patients with cutaneous leishmaniasis from an endemic central of Iran.

Eslami G, Hajimohammadi B, Jafari AA, Mirzaei F, Gholamrezai M, Anvari H, Khamesipour A.

Trop Biomed. 2014 Dec;31(4):592-9.

46.

P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER).

Soleimanifard S, Arjmand R, Saberi S, Khamesipour A, Kazemi M, Salehi M, Akbari M, Hejazi S.

Iran J Parasitol. 2014 Sep;9(3):423-8.

47.

The efficacy of hydro alcoholic extract of Seidlitzia rosmarinus on experimental zoonotic cutaneous leishmaniasis lesions in murine model.

Ahmadi M, Fata A, Khamesipour A, Rakhshandeh H, Miramin Mohammadi A, Salehi G, Monavari H.

Avicenna J Phytomed. 2014 Nov;4(6):385-91.

48.

Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis.

Eskandari F, Talesh GA, Parooie M, Jaafari MR, Khamesipour A, Saberi Z, Abbasi A, Badiee A.

Exp Parasitol. 2014 Nov;146:78-86. doi: 10.1016/j.exppara.2014.08.016. Epub 2014 Sep 20.

PMID:
25246326
49.

Preferential feeding success of laboratory reared Anopheles stephensi mosquitoes according to ABO blood group status.

Anjomruz M, Oshaghi MA, Pourfatollah AA, Sedaghat MM, Raeisi A, Vatandoost H, Khamesipour A, Abai MR, Mohtarami F, Akbarzadeh K, Rafie F, Besharati M.

Acta Trop. 2014 Dec;140:118-23. doi: 10.1016/j.actatropica.2014.08.012. Epub 2014 Aug 21.

PMID:
25151045
50.

Therapeutic vaccines for leishmaniasis.

Khamesipour A.

Expert Opin Biol Ther. 2014 Nov;14(11):1641-9. doi: 10.1517/14712598.2014.945415. Epub 2014 Jul 31. Review.

PMID:
25077737

Supplemental Content

Loading ...
Support Center